Skip to main content

Global Pyrogen Testing Market (2019-2023) to Exhibit a CAGR Exceeding 12% - Growing Preference for Value-Added Services - ResearchAndMarkets.com

The "Global Pyrogen Testing Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The pyrogen testing market will register a CAGR of over 12% by 2023.

Pharmaceutical and biotechnology companies, as well as research institutes, worldwide are increasingly focusing and spending on R&D for drug discovery and development due to the rising prevalence of chronic diseases. Such an increase in the number of projects fuels the demand for pyrogen testing products as these products are vital in analyzing and detecting the bacterial toxins in the raw materials used for the production of medicines.

This further leads to the high-volume generation of pyrogen testing products by various manufacturers. Thus, an increase in R&D spending in the pharmaceutical industry results in the development of new drugs. Such benefits have resulted in increased outsourcing to meet the rising global demand for new drugs, which will drive the growth of the global pyrogen testing market during the forecast period.

Growing preference for value-added services

Vendors in the global pyrogen testing market are increasingly focusing on providing additional software along with pyrogen testing systems to successfully integrate the results obtained using these systems into the existing laboratory workflow and to record data for use at a later stage for R&D studies. Data integration is the key factor here as the data generated by pyrogen testing products need to be collated with other exploratory data to generate actionable insights and progress toward informed decision-making.

Stringent regulatory policies

Manufacturers are affected by the stringent government regulations that control the manufacture, distribution, marketing, and sales of drugs and medical devices. The stringent regulations are expected to hinder the growth of the global pyrogen testing market during the forecast period.

Competitive Landscape

The pyrogen testing market appears to be fairly fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Players

  • Charles River
  • GenScript
  • Lonza
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY END-USER

  • Comparison by end-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023
  • Medical devices companies - Market size and forecast 2018-2023
  • Food and beverage manufacturers - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Charles River
  • GenScript
  • Lonza
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/research/2736vz/global_pyrogen?w=4

Contacts:

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.